Johanna Mercier sold $3.1M of Gilead Sciences (GILD)

Executed Aug 15 2025, disclosed Aug 18 2025, 3 days later.

Value, as filed

$3.1M

26,400 sh across 3 lots

Executed

Aug 15 2025

the trade date, as filed

Disclosed

Aug 18 2025

3 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Johanna Mercier Chief Commercial Officer profile →

Johanna Mercier (Chief Commercial Officer) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Gilead Sciences, Inc. (GILD). The largest single filing was $4.3M of GILD (27,800 sh across 2 lots, as filed), executed Feb 17.

The name

GILD

Gilead Sciences, Inc. GILD · Healthcare · 88 filings in 24 months ticker →

Healthcare · Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Johanna Mercier in GILD

GILDSALE Gilead Sciences, Inc. $469K
3,000 sh × $156.22
Exec Oct 15
Filed Oct 16 · 4:12 PM ET GILDSALE Gilead Sciences, Inc. $3.9M
28,000 sh across 2 lots
Exec Aug 17
Filed Aug 18 · 6:54 PM ET GILDSALE Gilead Sciences, Inc. $390K
3,000 sh × $129.92
Exec Jul 15
Filed Jul 16 · 4:54 PM ET GILDSALE Gilead Sciences, Inc. $315K
2,550 sh across 2 lots
Exec Jun 15
Filed Jun 16 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $3.6M
27,300 sh across 3 lots
Exec May 15
Filed May 18 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $423K
3,000 sh × $140.96
Exec Apr 15
Filed Apr 16 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $433K
3,000 sh × $144.23
Exec Mar 16
Filed Mar 17 · 5:30 PM ET GILDSALE Gilead Sciences, Inc. $4.3M
27,800 sh across 2 lots
Exec Feb 17
Filed Feb 18 · 5:30 PM ET